Bell Potter or any other broker is not going to 'make or break us'. That is the province of the FDA and the results of 2591 P2 trials.
Can't see the point of concentrating on broker analysis when our fate lies, first and foremost, on the performance of our drugs and how that perfornance is viewed by the regulatory authorities.
My opinion is that we are travelling pretty well in what is the main game.
Share Price, page-1011
-
- There are more pages in this discussion • 10,464 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.34 |
Change
-0.410(2.60%) |
Mkt cap ! $1.960B | |||
| Open | High | Low | Value | Volume |
| $15.88 | $15.93 | $15.34 | $6.463M | 415.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 6044 | $15.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.57 | 1411 | 2 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |